VYNE Therapeutics VYNE
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 0.58 | 105.31 | -0.11 | -5,219 | -5 | |
| 2025Q3 | 0.34 | 104.93 | -0.17 | -7,792 | -7 | |
| 2025Q2 | 1.65 | -0.13 | -7,542 | -6 | ||
| 2025Q1 | 1.58 | 106.90 | -0.20 | -9,197 | -9 | |
| 2024Q4 | 3.35 | 106.33 | -0.28 | -12,770 | -12 | |
| 2024Q3 | 1.88 | 107.68 | -0.28 | -13,091 | -12 | |
| 2024Q2 | 1.97 | 110.65 | -0.22 | -10,396 | -9 | |
| 2024Q1 | 3.07 | 118.25 | -0.15 | -7,380 | -6 | |
| 2023Q4 | 2.33 | 111.05 | 4.04 | -6,832 | -6 | |
| 2023Q3 | 4.04 | 102.69 | -2.00 | -6,233 | -7 | |
| 2023Q2 | 4.10 | 102.79 | -3.08 | -10,318 | -10 | |
| 2023Q1 | 3.08 | 104.69 | -1.74 | -5,875 | -6 | |
| 2022Q4 | 2.70 | 103.05 | -3.10 | -7,984 | -10 | |
| 2022Q3 | 4.02 | 100.84 | -2.97 | -9,333 | -9 | |
| 2022Q2 | 7.00 | 100.63 | -2.72 | -8,287 | -8 | |
| 2022Q1 | 11.70 | 99.97 | 1.51 | -8,691 | 5 | |
| 2021Q4 | 18.36 | 100.07 | -3.68 | -37,967 | -12 | |
| 2021Q3 | 25.02 | 99.90 | -7.38 | -36,689 | -21 | |
| 2021Q2 | 63.18 | 99.76 | -7.02 | -28,455 | -20 | |
| 2021Q1 | 123.21 | 99.71 | -7.56 | -19,431 | -21 |